DBV Technologies | Eget Kapital Och Reservfonder



Equity Capital And Reserves Ändra Datum
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
DBV Technologies USD 27.4M 26.63M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
United Therapeutics USD 6.81B 363.2M 2025-03



DBV Technologies Eget Kapital Och Reservfonder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.